{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:43:36Z","timestamp":1790775816978,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2020\/37\/B\/NZ7\/03380"],"award-info":[{"award-number":["2020\/37\/B\/NZ7\/03380"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.advms.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:33:35Z","timestamp":1742067215000},"page":"219-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Determinants and dynamics of the seroprevalence of anti-SARS-CoV-2 antibodies in Poland"],"prefix":"10.1016","volume":"70","author":[{"given":"Justyna","family":"Adamczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-2581","authenticated-orcid":false,"given":"Karol Adam","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1113-0997","authenticated-orcid":false,"given":"Sebastian","family":"So\u0142omacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-8026","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Kazberuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-5075","authenticated-orcid":false,"given":"Magdalena","family":"Chlabicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0072-2180","authenticated-orcid":false,"given":"Piotr","family":"Czupryna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-0068","authenticated-orcid":false,"given":"Justyna","family":"Dunaj-Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Citko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-5816","authenticated-orcid":false,"given":"Pawe\u0142","family":"Sowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5977-0745","authenticated-orcid":false,"given":"Marlena","family":"Dubat\u00f3wka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"\u0141api\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-3260","authenticated-orcid":false,"given":"\u0141ukasz","family":"Kiszkiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-0605","authenticated-orcid":false,"given":"\u0141ukasz","family":"Szczerbi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-607X","authenticated-orcid":false,"given":"Piotr Pawe\u0142","family":"Laskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-4217","authenticated-orcid":false,"given":"Maciej","family":"Alimowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-8785","authenticated-orcid":false,"given":"Anna","family":"Moniuszko-Malinowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7150\/ijbs.59272","article-title":"Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy","volume":"18","author":"Jiang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.advms.2025.03.002_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines11010013","article-title":"A\u00a0closer look at ACE2 signaling pathway and processing during COVID-19 infection: identifying possible targets","volume":"11","author":"Sodhi","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.advms.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41423-021-00752-2","article-title":"Neutralizing antibodies for the prevention and treatment of COVID-19","volume":"18","author":"Du","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.advms.2025.03.002_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/22221751.2020.1773324","article-title":"Patterns of IgG and IgM antibody response in COVID-19 patients","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.advms.2025.03.002_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.655896","article-title":"IgA antibodies and IgA deficiency in SARS-CoV-2 infection","volume":"11","author":"Quinti","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.advms.2025.03.002_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2023.114224","article-title":"The dominance of co-circulating SARS-CoV-2 variants in wastewater","volume":"253","author":"Pilapil","year":"2023","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.advms.2025.03.002_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004107","article-title":"Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies","volume":"19","author":"Bergeri","year":"2022","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.advms.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21141\/PJP.2020.09","article-title":"Cross-contamination in molecular diagnostic laboratories in low- and middle-income countries: a challenge to COVID-19 testing","volume":"5","author":"Albano","year":"2020","journal-title":"PJP"},{"issue":"1","key":"10.1016\/j.advms.2025.03.002_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28241","article-title":"In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing","volume":"95","author":"Sharma","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.advms.2025.03.002_bib10","first-page":"5860","article-title":"Multimorbidity patterns in the urban population in Poland","volume":"12","author":"Chlabicz","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.advms.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.advms.2021.03.005","article-title":"The first SARS-CoV-2 genetic variants of concern (VOC) in Poland: the concept of a comprehensive approach to monitoring and surveillance of emerging variants","volume":"66","author":"Charkiewicz","year":"2021","journal-title":"Adv Med Sci"},{"issue":"61","key":"10.1016\/j.advms.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: the \u201eggstatsplot\u201d approach","volume":"6","author":"Patil","year":"2012","journal-title":"J\u00a0Open Source Softw"},{"key":"10.1016\/j.advms.2025.03.002_bib14","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.33.2200619","article-title":"Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, may to july 2022","volume":"27","author":"Castilla","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.advms.2025.03.002_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266270","article-title":"Large-scale serosurveillance of COVID-19 in Japan: acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak","volume":"17","author":"Ren","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3201\/eid2805.220278","article-title":"SARS-CoV-2 seroprevalence after third wave of infections, South Africa","volume":"28","author":"Kleynhans","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.advms.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1515\/mr-2021-0034","article-title":"Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic","volume":"2","author":"Wang","year":"2022","journal-title":"Med Rev"},{"key":"10.1016\/j.advms.2025.03.002_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41564-022-01166-0","article-title":"COVID vaccination in older adults","volume":"7","author":"H\u00e4gg","year":"2022","journal-title":"Nat Microbiol"},{"issue":"4","key":"10.1016\/j.advms.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/vaccines11040724","article-title":"Humoral response in hemodialysis patients post-SARS-CoV-2 mRNA vaccination: a systematic review of literature","volume":"11","author":"Notarte","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.advms.2025.03.002_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1001\/jamainternmed.2020.4130","article-title":"Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-may 12, 2020","volume":"180","author":"Havers","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.advms.2025.03.002_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijid.2020.10.011","article-title":"Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: an up-to-date review","volume":"101","author":"Lai","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.advms.2025.03.002_bib22","first-page":"401","article-title":"Early and high SARS-CoV-2 neutralizing antibodies are associated with severity in COVID-19 patients from India","volume":"105","author":"Shrivastava","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.advms.2025.03.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110629","article-title":"SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia","volume":"130","author":"Chen","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.advms.2025.03.002_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.628971","article-title":"Disease severity, fever, age, and sex correlate with SARS-CoV-2 neutralizing antibody responses","volume":"11","author":"Schlickeiser","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2025.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81862-9","article-title":"SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity","volume":"11","author":"Trinit\u00e9","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.advms.2025.03.002_bib26","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1080\/22221751.2020.1823890","article-title":"SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease","volume":"9","author":"Wang","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.advms.2025.03.002_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0240","article-title":"Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome","volume":"5","author":"R\u00f6ltgen","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.advms.2025.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.811952","article-title":"Measurement of SARS-CoV-2 antibody titers improves the prediction accuracy of COVID-19 maximum severity by machine learning in non-vaccinated patients","volume":"13","author":"Kurano","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2025.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1117464","article-title":"Long COVID: a review and proposed visualization of the complexity of long COVID","volume":"14","author":"Perumal","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2025.03.002_bib30","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41564-022-01235-4","article-title":"SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope","volume":"7","author":"He","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.advms.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.advms.2025.03.002_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02659-4","article-title":"Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients","volume":"11","author":"Chansaenroj","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.advms.2025.03.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267102","article-title":"Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients","volume":"17","author":"Chansaenroj","year":"2022","journal-title":"PLoS One"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112625000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112625000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:25:49Z","timestamp":1762561549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112625000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1896112625000203"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2025.03.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants and dynamics of the seroprevalence of anti-SARS-CoV-2 antibodies in Poland","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}